Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (14,127,610)	$ (23,970,277)
Adjustments to reconcile net loss to net cash from operating activities:
Net unrealized gain on equity securities at fair value	(790,405)	(49,407)
Net (income) loss from equity method investments at fair value	(421,696)	767,066
Net realized gain on investments	(24,302)	(132,434)
Impairment loss on assets held for sale	1,687,783	0
Impairment loss	0	9,500,167
Straight-line rent	(205,958)	(154,952)
Depreciation and amortization	9,141,627	11,432,557
Amortization of deferred financing costs and debt mark-to-market	1,367,580	1,377,272
Accretion of above (below) market lease, net	(161,645)	(544,103)
Stock-based compensation	37,363	628,137
Changes in assets and liabilities:
Investments income, rents and other receivables	(514,243)	(890,103)
Prepaid expenses and other assets	137,361	125,104
Deferred rent and other liabilities	(13,123)	50,398
Accounts payable and accrued liabilities	(1,092,443)	144,376
Due to related entities	1,670,483	26,097
Net cash from operating activities	(3,309,228)	(1,690,102)
Cash flows from investing activities:
Proceeds from sale of investments	3,709,739	962,721
Investments in real estate assets	(9,149,758)	(18,899,433)
Purchase of investments	(3,695,650)	(1,183,597)
Net cash from investing activities	(9,135,669)	(19,120,309)
Cash flows from financing activities:
Borrowing under mortgage notes payable	22,803,277	48,477,670
Payments on mortgage notes payable	(11,662,553)	(48,876,780)
Borrowing under line of credit	412,000	9,588,000
Proceeds from notes payable	3,625,438	1,115,000
Payments on notes payable	(2,047,342)	(223,898)
Payment of financing fees	(918,460)	(2,321,155)
Dividends to common stockholders	0	(4,802,866)
Proceeds from issuance of common stock	317,121	3,794,260
Proceeds from issuance of pre-funded warrants	0	1,935,455
Payment on finance lease liabilities	(274,028)	(234,109)
Payment of selling commissions and fees	(381,324)	(1,876,917)
Contributions by non-controlling interests holders	0	5,574,804
Distributions to non-controlling interests holders	(1,527,214)	(1,491,165)
Redemptions of common stock	(1,784)	(24)
Capital pending acceptance	(13,411)	(283,589)
Net cash from financing activities	12,137,311	11,849,393
Net decrease in cash, cash equivalents and restricted cash	(307,586)	(8,961,018)
Cash, cash equivalents and restricted cash at beginning of the year	4,116,321	13,077,339
Cash, cash equivalents and restricted cash at end of the year	3,808,735	4,116,321
Cash and cash equivalents at end of the year	3,517,313	3,627,360
Restricted cash at end of the year	202,886	328,239
Cash at end of the year classified as assets held for sale	88,536	160,722
Total cash, cash equivalents, restricted cash and cash classified as held for sale at end of the year	3,808,735	4,116,321
Supplemental disclosure of non-cash financing activities and other cash flow information:
Cash paid for interest	7,990,528	7,203,282
Conversion of Operating Partnership Series A Preferred Units to common stock	118,082	0
Reclassification of prepaid expenses and other assets to mortgage notes payable, net	294,042	0
Capitalized construction in progress outstanding as accounts payable and accrued expenses	0	1,912,673
Stock-based compensation	0	665,500
Operating Partnership Class A conversion to common stock	0	3,301
Green Valley Medical Center, LP [Member]
Supplemental disclosure of non-cash financing activities and other cash flow information:
Issuance of the Operating Partnership Preferred Units for the purchase of Green Valley Medical Center, LP (Note 1)	0	2,712,194
Fair value of assets acquired from consolidation of Green Valley Medical Center, LP	0	13,621,753
Fair value of liabilities assumed from consolidation of Green Valley Medical Center, LP	0	8,904,457
Martin Plaza Associates, LP [Member]
Supplemental disclosure of non-cash financing activities and other cash flow information:
Conversion of notes receivable to preferred equity of Martin Plaza Associates, LP	0	200,000
Series A Preferred Stock [Member]
Cash flows from financing activities:
Dividends to preferred stockholders	(943,328)	(952,669)
Proceeds from issuance of preferred stock	1,164,985	226,100
Redemptions of preferred stock	(88)	(5,531)
Supplemental disclosure of non-cash financing activities and other cash flow information:
Issuance of preferred stock through reinvestment of dividends	187,418	192,770
Issuance of Operating Partnership Preferred Units - Series A through reinvestment of dividends	112,134	98,968
Preferred Series conversion to common stock	2,301,515	318,161
Series B Preferred Stock [Member]
Cash flows from financing activities:
Dividends to preferred stockholders	(63,393)	(40,449)
Proceeds from issuance of preferred stock	332,488	1,647,579
Redemptions of preferred stock	(13)	0
Supplemental disclosure of non-cash financing activities and other cash flow information:
Issuance of preferred stock through reinvestment of dividends	25,697	14,503
Increase in liquidation preference of Series B preferred stock	273,582	204,889
Increase in liquidation preference of Operating Partnership Preferred Units - Series B	97,227	97,229
Preferred Series conversion to common stock	151,462	0
Conversion of Series B preferred stock liquidation preference (9% non-cash dividend) to common stock	8,804	0
Series C Preferred Stock [Member]
Cash flows from financing activities:
Dividends to preferred stockholders	(51,060)	0
Proceeds from issuance of preferred stock	1,366,000	0
Supplemental disclosure of non-cash financing activities and other cash flow information:
Issuance of preferred stock through reinvestment of dividends	1,508	0
Series A Common Stock [Member]
Cash flows from financing activities:
Proceeds from issuance of common stock warrants	0	376,268
Series B Common Stock [Member]
Cash flows from financing activities:
Proceeds from issuance of common stock warrants	$ 0	$ 223,409

Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Jun. 30, 2025
Real estate assets
Land	$ 42,566,256	$ 42,566,256
Building, fixtures and improvements	189,054,883	182,879,586
Intangible lease assets	10,931,578	11,686,822
Less: accumulated depreciation and amortization	(29,864,947)	(24,358,852)
Total real estate assets, net	212,687,770	212,773,812
Cash and cash equivalents	3,517,313	3,627,360
Restricted cash	202,886	328,239
Investments, at fair value	2,550,146	1,749,528
Equity method investments, at fair value	2,347,147	2,125,451
Investments income, rents and other receivables	2,871,934	2,227,630
Prepaid expenses and other assets	856,097	1,184,801
Assets held for sale, net	10,256,507	11,975,357
Total assets	235,289,800	235,992,178
Liabilities
Mortgage notes payable, net	131,867,757	120,417,074
Line of credit, net	10,000,000	9,449,389
Notes payable, net	3,863,717	2,567,118
Deferred rent and other liabilities	1,490,021	1,513,283
Finance lease liabilities	1,672,528	1,898,005
Dividend payable	734,333	715,498
Accounts payable and accrued liabilities	3,363,535	4,514,142
Below-market lease liabilities, net	221,007	530,474
Due to related entities	2,197,623	167,764
Capital pending acceptance		13,411
Liabilities held for sale	652,274	664,577
Total liabilities	156,062,795	142,450,735
Equity
Common stock, $0.0001 par value, 80,000,000 shares authorized; 2,512,270.00 and 1,578,192.98 shares issued and outstanding as of June 30, 2026 and June 30, 2025, respectively.	251	158
Additional paid-in capital	148,073,839	145,050,643
Accumulated deficit	(104,298,175)	(85,192,267)
Total stockholders’ equity	43,776,005	59,858,623
Non-controlling interests	35,451,000	33,682,820
Total equity	79,227,005	93,541,443
Total liabilities and equity	235,289,800	235,992,178
Series A Preferred Stock [Member]
Equity
Preferred stock	73	77
Series B Preferred Stock [Member]
Equity
Preferred stock	12	12
Series C Preferred Stock [Member]
Equity
Preferred stock	$ 5	$ 0